Compassionate Use of Pozelimab

Identification of Celiac Ganglia

NCT01010360 ·Status: COMPLETED

Rituximab to Treat Neuropathy With Anti-MAG Antibodies

NCT00050245 ·Status: COMPLETED ·Phase: PHASE2

POEMS Syndrome Treatment With Lenalidomide

NCT01639898 ·Status: COMPLETED ·Phase: PHASE2

Autologous Transplant To End NMO Spectrum Disorder

NCT03829566 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3

A Study to Examine the Safety, Tolerability and Biological Effects of Single Doses of Subcutaneously and Intravenously Administered Pozelimab as Monotherapy and in Combination With Single Doses of Subcutaneously Administered Cemdisiran in Adult Japanese Healthy Volunteers

NCT04940364 ·Status: COMPLETED ·Phase: PHASE1

Rituximab Therapy in Anti-Myelin Associated Glycoprotein Patients With Characteristics of Good Responders

NCT05136976 ·Status: RECRUITING ·Phase: PHASE3

A Pilot Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Generalized Myasthenia Gravis

NCT01555580 ·Status: UNKNOWN ·Phase: EARLY_PHASE1

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06290141 ·Status: RECRUITING ·Phase: PHASE3

Clinical Study of Cizutamig in Generalized Myasthenia Gravis (gMG)

NCT07215650 ·Status: RECRUITING ·Phase: PHASE1

An Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of Subcutaneous Zilucoplan in Participants With Generalized Myasthenia Gravis Who Were Previously Receiving Intravenous Complement Component 5 Inhibitors

NCT05514873 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of ULSC on Disease Severity and Steroid Tapering in Participants With Dermatomyositis/ Polymyositis (DM/PM), Also Known as Idiopathic Inflammatory Myopathy (IIM)

NCT07160205 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Study of the Efficacy and Safety for Rituximab in Myalgia Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)

NCT06952413 ·Status: RECRUITING ·Phase: PHASE2

Rituximab in Chronic Inflammatory Demyelinating Polyneuropathy

NCT04480450 ·Status: WITHDRAWN ·Phase: PHASE2

Allogeneic Mitochondria (PN-101) Transplantation for Refractory Polymyositis or Dermatomyositis

NCT04976140 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis

NCT02115997 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis

NCT03315130 ·Status: COMPLETED ·Phase: PHASE2

Study of CIDP Patients During IVIG Treatment

NCT00305266 ·Status: COMPLETED

A Study to Evaluate the PK, Safety and Tolerability of GMI-1271 With and Without Filgrastim in Healthy Adult Subjects

NCT02703051 ·Status: COMPLETED ·Phase: PHASE1

Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM)

NCT00106184 ·Status: COMPLETED ·Phase: PHASE2

Phase 1 Study of ULSC in Patients With Polymyositis (PM) and Dermatomyositis (DM)

NCT04723303 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Disease-Modifying Treatments for Myasthenia Gravis

NCT03490539 ·Status: COMPLETED

RIMAG Study: Trial of Rituximab Versus Placebo in Polyneuropathy Associated With Anti-MAG IgM Monoclonal Gammopathy

NCT00259974 ·Status: COMPLETED ·Phase: PHASE3

Pharmacokinetic, Immunological and Biochemical Sample Collection and Analysis of a Tysabri Patient Cohort

NCT01070719 ·Status: COMPLETED

Phase 3b Study to Evaluate Skeletal Response to Eliglustat in Adult Patients Who Completed Phase 2 or Phase 3 Studies

NCT02536755 ·Status: COMPLETED ·Phase: PHASE3

An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease

NCT00701129 ·Status: COMPLETED ·Phase: PHASE4